Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Health
Storm Newton

Hundreds of blood cancer patients to benefit from new treatment

Hundreds of people with a rare and incurable type of blood cancer are set to benefit from a new drug that has been recommended for use on the NHS (Jeff Moore.PA) - (PA Wire)

Hundreds of people with a rare and incurable type of blood cancer are set to benefit from a new drug that has been recommended for use on the NHS.

Elranatamab, known as Elrexfio and made by Pfizer, is an injection that treats myeloma, a cancer that develops in the bone marrow when abnormal plasma cells grow too quickly.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.